Nordics: Difference between revisions

From Research Wiki
← Older editNewer edit →
Fixed doubled title
New page
Line 1: Line 1:
__NOTOC__
__NOTOC__
Norway, Sweden, Denmark, Finland — digital health hub.
Norway, Sweden, Denmark, Finland — digital health hub.


== Norway 🇳🇴 ==
== Norway ==
{|
{| class="wikitable"
|-
|-
! Company !! Category !! Funding !! Status
! Company !! Category !! Funding !! Status
|-
|-
| [[Noteless]] || AI Clinical Documentation || €3.5M Seed || Active, 3,000+ clinicians
| [[Noteless]] || AI Clinical Documentation || EUR 3.5M Seed || Active, 3,000+ clinicians
|-
|-
| [[Dr. Dropin]] || Digi-Physical Healthcare || €19.2M || Expanding to London
| [[Dr. Dropin]] || Digi-Physical Healthcare || EUR 19.2M || Expanding to London
|-
|-
| [[Nolla Health]] || AI Dermatology || $4.5M || Launched in US
| [[Nolla Health]] || AI Dermatology || $4.5M || Launched in US
|-
|-
| [[Actithera]] || Radiopharma / Radioligand Therapy || $75.5M Series A || Pipeline development
| [[Actithera]] || Radiopharma || $75.5M Series A || Pipeline development
|-
|-
| [[Dignio]] || Remote Patient Monitoring || Acquired by [[Summa Equity]] || NHS pilot in UK
| [[Dignio]] || Remote Patient Monitoring || Acquired by [[Summa Equity]] || NHS pilot in UK
Line 20: Line 19:
| [[Holberg EEG]] || AI Neurodiagnostics || Acquired by Natus || Global autoSCORE launch
| [[Holberg EEG]] || AI Neurodiagnostics || Acquired by Natus || Global autoSCORE launch
|-
|-
| [[Lioness Medtech]] || Portable MRI / Brain Imaging || N/A (partnership) || First portable MRI in Norway
| [[Lioness Medtech]] || Portable MRI || Partnership || First portable MRI in Norway
|-
|-
| [[No Isolation]] || Social Impact Robots || Undisclosed || Deployed in UK+
| [[No Isolation]] || Social Impact Robots || Undisclosed || Deployed in UK+
Line 27: Line 26:
|}
|}


== Sweden 🇸🇪 ==
== Sweden ==
{|
{| class="wikitable"
|-
|-
! Company !! Category !! Funding !! Status
! Company !! Category !! Funding !! Status
|-
|-
| [[Neko Health]] || Preventive Health / AI Scanning || $260M ($1.8B val) || Clinics in Stockholm, London, NYC planned
| [[Neko Health]] || Preventive Health / AI Scanning || $260M ($1.8B val) || Stockholm, London, NYC
|-
|-
| [[Tandem Health]] || AI Clinical OS || €42.6M Series A || 200K+ NHS staff, 5 EU markets
| [[Tandem Health]] || AI Clinical OS || EUR 42.6M Series A || 200K+ NHS staff, 5 EU markets
|-
|-
| [[Kry / Livi]] || Telehealth || $316M+ (~$2B val) || Profitable, 5 countries
| [[Kry / Livi]] || Telehealth || $316M+ (~$2B val) || Profitable, 5 countries
Line 40: Line 39:
| [[Mindler]] || Digital Mental Health || $8.7M || Acquired ieso UK, Medified FI
| [[Mindler]] || Digital Mental Health || $8.7M || Acquired ieso UK, Medified FI
|-
|-
| [[Acorai]] || Cardiac Monitoring || €4.2M+ || FDA Breakthrough Device designation
| [[Acorai]] || Cardiac Monitoring || EUR 4.2M+ || FDA Breakthrough Device
|-
|-
| [[Dentio]] || AI Dental || $2.3M (a16z) || Early stage
| [[Dentio]] || AI Dental || $2.3M (a16z) || Early stage
|-
|-
| [[Cellcolabs]] || Stem Cell Manufacturing || $12M || Bryan Johnson-backed
| [[Cellcolabs]] || Stem Cell Mfg || $12M || Bryan Johnson-backed
|-
|-
| [[Meela]] || Patient-Therapist Matching || €2.6M Seed || Gothenburg-based
| [[Meela]] || Patient-Therapist Match || EUR 2.6M Seed || Gothenburg
|-
|-
| [[Sakura]] || B2B Mental Health || Pre-seed || Female-founded
| [[Sakura]] || B2B Mental Health || Pre-seed || Female-founded
|-
|-
| [[TrialMe]] || Femtech / Clinical Trials || Undisclosed || Fixing gender gap in trials
| [[TrialMe]] || Femtech / Clinical Trials || Undisclosed || Gender gap in trials
|-
|-
| [[Loovi]] || Preventive Health || €1M || Early stage
| [[Loovi]] || Preventive Health || EUR 1M || Early stage
|-
|-
| [[Doctrin]] || Digital Primary Care || Undisclosed || New CEO, UK expansion
| [[Doctrin]] || Digital Primary Care || Undisclosed || New CEO, UK expansion
|-
|-
| [[Min Doktor]] || Online Healthcare || €4.7M || Struggling to scale
| [[Min Doktor]] || Online Healthcare || EUR 4.7M || Struggling to scale
|-
|-
| [[BOOST Pharma]] || Cell Therapy || €3.1M+ || RoslinCT partnership
| [[BOOST Pharma]] || Cell Therapy || EUR 3.1M+ || RoslinCT partnership
|}
|}


== Key Investors ==
== Funding & Support ==
See [[Investors]] for the full list. Key names: [[Kinnevik]], [[Northzone]], [[Alliance VC]], [[Summa Equity]], [[Novo Holdings]].
* [[Soft Funding Norway]] — Norwegian grants, tax credits, EU programs
* [[Investors Norway Digital Health]] — Norwegian VCs and funds
* [[Nordic Health Incubators]] — incubators, accelerators, university TTOs
* [[Investors]] — full Nordic/EU investor list
* [[Soft Funding]] — EU-wide soft funding


== Key Topics ==
== Key Topics ==
* [[Soft Funding]] — Norwegian and EU grant programs
* [[AI Clinical Documentation]] — [[Noteless]], [[Tandem Health]], [[Dentio]]
* [[AI Clinical Documentation]] — hottest subsector: [[Noteless]], [[Tandem Health]], [[Dentio]]
* [[Telehealth]] — [[Kry / Livi]], [[Dr. Dropin]], [[Dignio]]
* [[Telehealth]] — [[Kry / Livi]], [[Dr. Dropin]], [[Dignio]]
* [[Preventive Health]] — [[Neko Health]], [[Loovi]], [[Cellcolabs]]
* [[Preventive Health]] — [[Neko Health]], [[Loovi]], [[Cellcolabs]]
* [[Blood Tech]] — [[Actithera]], [[Acorai]], [[Cellcolabs]], [[BOOST Pharma]]
* [[Knowledge Graphs in Health]] — [[AIDAVA]] and related projects


== Ecosystem Notes ==
== Ecosystem Notes ==
Sweden significantly ahead of Norway in digital health funding and unicorn creation. Norway more device/RPM focused; Sweden dominates AI-first health companies. Actithera's $75.5M Series A (largest Norwegian health raise) shows radiopharma attracting big capital. a16z entering Nordics via [[Dentio]] signals US VC interest.
Sweden significantly ahead in funding and unicorns. Norway more device/RPM focused. Actithera's $75.5M is largest Norwegian health raise. a16z entering Nordics via [[Dentio]].
 
== Sources ==
See [[Publications]] for all source publications.
 
== See Also ==
* [[:Category:Company]]
* [[:Category:Norway]]
* [[:Category:Sweden]]


[[Category:Region]]
[[Category:Region]]

Revision as of 18:05, 13 April 2026

Norway, Sweden, Denmark, Finland — digital health hub.

Norway

Company Category Funding Status
Noteless AI Clinical Documentation EUR 3.5M Seed Active, 3,000+ clinicians
Dr. Dropin Digi-Physical Healthcare EUR 19.2M Expanding to London
Nolla Health AI Dermatology $4.5M Launched in US
Actithera Radiopharma $75.5M Series A Pipeline development
Dignio Remote Patient Monitoring Acquired by Summa Equity NHS pilot in UK
Holberg EEG AI Neurodiagnostics Acquired by Natus Global autoSCORE launch
Lioness Medtech Portable MRI Partnership First portable MRI in Norway
No Isolation Social Impact Robots Undisclosed Deployed in UK+
Journalia AI Healthcare Admin $1M Early stage

Sweden

Company Category Funding Status
Neko Health Preventive Health / AI Scanning $260M ($1.8B val) Stockholm, London, NYC
Tandem Health AI Clinical OS EUR 42.6M Series A 200K+ NHS staff, 5 EU markets
Kry / Livi Telehealth $316M+ (~$2B val) Profitable, 5 countries
Mindler Digital Mental Health $8.7M Acquired ieso UK, Medified FI
Acorai Cardiac Monitoring EUR 4.2M+ FDA Breakthrough Device
Dentio AI Dental $2.3M (a16z) Early stage
Cellcolabs Stem Cell Mfg $12M Bryan Johnson-backed
Meela Patient-Therapist Match EUR 2.6M Seed Gothenburg
Sakura B2B Mental Health Pre-seed Female-founded
TrialMe Femtech / Clinical Trials Undisclosed Gender gap in trials
Loovi Preventive Health EUR 1M Early stage
Doctrin Digital Primary Care Undisclosed New CEO, UK expansion
Min Doktor Online Healthcare EUR 4.7M Struggling to scale
BOOST Pharma Cell Therapy EUR 3.1M+ RoslinCT partnership

Funding & Support

Key Topics

Ecosystem Notes

Sweden significantly ahead in funding and unicorns. Norway more device/RPM focused. Actithera's $75.5M is largest Norwegian health raise. a16z entering Nordics via Dentio.

Retrieved from "https://wiki.stamen.health/index.php?title=Nordics&oldid=127"